Witnesses at the April 8 hearing told legislators biosimilars save patients and taxpayers money, that pharmacy benefit ...

According to the analysis, the U.S. healthcare system, including patients, employers and taxpayers, saved $408 billion in 2022 by using FDA-approved generic and biosimilar drugs. More than 90% of ...

Drugmaker Amgen on Tuesday launched a biosimilar to the widely-prescribed Humira, giving consumers an alternative to the world's top-selling rheumatoid arthritis drug. The new drug, Amjevita ...

There's a catch, however. Developing a biosimilar is much more challenging than developing a generic version of a chemically synthesized "small molecule" drug. That's because biosimilars ...

CVS Health is launching a new subsidiary unit, Cordavis, that will collaborate with drug manufacturers to produce biosimilar products, or medications that are near identical to an already approved ...

Here's what to know about biosimilar drugs. Jessica was a writer on the Wellness team, with a focus on health technology, eye care, nutrition and finding new approaches to chronic health problems.

Beinfeld 's team found no evidence that increased competition from biosimilars pushed up drug spending. Employer plays, insurers and other payers tend to take a few years to begin covering ...